American Association for Cancer Research

AACR Cancer Policy Monitor

Bookmark and Share
CPM
November 2011

 


 

SUPERCOMMITTEE STALEMATE TRIGGERS SPENDING CUTS            

Federal programs face $1.2 trillion in automatic cuts

The congressional panel that was charged with recommending more than $1 trillion in federal savings failed to reach a consensus before its Nov. 23 deadline. The failure of the panel’s nearly three-month effort to find a  compromise on taxes and entitlement programs leaves a wide range of federal programs, like the National Institutes of Health (NIH), facing automatic spending cuts. Read more

 


 

CONGRESS DELAYS DECISION ON FY2012 NIH FUNDING

Congress extends continuing resolution; approves funding for FDA

Last week, Congress sent President Obama the first installment of the 12 overdue fiscal year 2012 appropriations bills. Included in the spending package was the bill that funds the U.S. Food and Drug Administration (FDA), the regulatory agency that is the nexus between new discoveries and cancer care. Despite the increase for FDA the two chambers still remain deeply divided over funding for the National Cancer Institute (NCI) and its parent agency, the National Institutes of Health (NIH). Read more

 


 

SENATE RESOLUTION TO COMMEMORATE NATIONAL CANCER ACT   

Encourage your senators to lend their support

U.S. Senators Sherrod Brown (D-Ohio), Jerry Moran (R-Kan.) and John Kerry (D-Mass.) are preparing to introduce a congressional resolution that reaffirms the national commitment to understanding and controlling cancer. Read more

 


 

AACR ADDRESSES RULES GOVERNING HUMAN SUBJECTS RESEARCH

Joint comments with ASCO and AACI support framework for updating rules, but encourage wider harmonization efforts

The U.S. Department of Health and Human Services (HHS) is poised to modify rules governing human subjects research according to an Advanced Notice of Proposed Rulemaking (ANPRM) issued over the summer. In response, the AACR has collaborated with the American Society of Clinical Oncology (ASCO) and the Association of American Cancer Institutes (AACI) to submit joint, formal comments to the department expressing general support for most aspects of the proposed reforms, but also identifying specific concerns about some of the changes that might be forthcoming. Read more

 


Top